Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement

BACKGROUND: The objective of this study was to investigate the efficacy of topical 0.1% tacrolimus in treating refractory allergic conjunctivitis with proliferative lesions and/or corneal involvement. METHODS: This prospective observational study included 1436 patients with refractory allergic conju...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Fukushima, Atsuki, Ohashi, Yuichi, Ebihara, Nobuyuki, Uchio, Eiichi, Okamoto, Shigeki, Kumagai, Naoki, Shoji, Jun, Takamura, Etsuko, Nakagawa, Yayoi, Namba, Kenichi, Fujishima, Hiroshi, Miyazaki, Dai
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2014
Gaiak:
Clinical Science
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4112440/
https://ncbi.nlm.nih.gov/pubmed/24695688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2013-304453
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak